West Pharmaceutical Services Inc (WST)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) for West Pharmaceutical Services Inc, based on the provided data, is not available for all the reporting periods from March 31, 2020, to December 31, 2024.
DSO is a financial ratio that indicates the average number of days a company takes to collect payment after a sale has been made. A lower DSO is generally favorable as it signifies faster collection of accounts receivable and better cash flow management.
Unfortunately, without specific DSO values provided in the data, it is challenging to assess West Pharmaceutical Services Inc's efficiency in collecting payments from customers and managing its accounts receivable turnover. Analyzing DSO trends over time could help identify any improvements or deterioration in the company's collection practices.
In absence of this information, other financial ratios and metrics should be considered to gain a comprehensive understanding of West Pharmaceutical Services Inc's financial performance and efficiency in managing its working capital.
Peer comparison
Dec 31, 2024